Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes-Reference-Cited by-同舟云学术

Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes

Published:2015-08-08 Issue:3 Volume:15 Page:227-232
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Vuylsteke Valerie,Chastain Lisa M.,Maggu Geeta A.,Brown Crystal

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s40268-015-0099-3/fulltext.html

Reference16 articles.

1. International Diabetes Foundation. Diabetes: facts and figures. Available from: http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures . Cited 16 Nov 2013.

2. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992;15:318–68.

3. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1334–79.

4. Garber AJ, Abrahamson MJ, Barzilay JI, et al. AACE comprehensive diabetes management algorithm 2013 consensus statement. Endocr Pract. 2013;19(Suppl 2):1–48.

5. Qaseem A, Humphrey L, Sweet D, et al. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156:218–31.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin;Medical Principles and Practice;2024-08-12

2. Glucokinase activators and imeglimin: new weaponry in the armamentarium against type 2 diabetes;BMJ Open Diabetes Research & Care;2024-08

3. Type 2 diabetes mellitus: Novel targets and multitarget-directed phytotherapy;Antidiabetic Medicinal Plants;2024

4. DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-UHPLC METHOD FOR THE ESTIMATION OF IMEGLIMIN HYDROCHLORIDE USED FOR THE TREATMENT OF METABOLIC DISORDER DIABETES MELLITUS;International Journal of Applied Pharmaceutics;2023-11-07

5. The role of Imeglimin in glycemic control, beta cell function and safety outcomes in patients with type 2 diabetes mellitus: A comprehensive meta-analysis;Diabetes Epidemiology and Management;2023-10